The association between dream recall and a strong genetic risk factor for AD (APOE ε4), as well as between dream recall and cognitive decline, dementia and an AD biomarker (p-tau217), can be considered a Mendelian randomization test corroborating the relationship between dream recall and AD. The gene discussed is APOE; the disease is Alzheimer disease.